Definitive Contract 75A50120C00189

Award Date 9/28/20
Potential Completion Date 7/29/22
Potential Value $694K
Ultimate Awardee
Danaher Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Miami, FL 33196, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
500
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,226,322.00 definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Beckman Coulter Inc., a subsidiary of Danaher Corporation. The contract is for the provision of Beckman Coulter's Monocyte Distribution Width (MDW) and predictive analytic algorithms for sepsis detection. This contract was not set aside. The original federal contract opportunity was a Broad Agency Announcement from BARDA seeking...
This is a $725,368.36 Firm Fixed Price (FFP) contract awarded to Beckman Coulter, Inc., a subsidiary of Danaher Corporation, by the Office of the Assistant Secretary for Preparedness and Response (ASPR). The contract is for a research and development effort to develop a rapid detection test for severe, dysregulated host immune response to infection in pediatrics. The contract has a base period of performance through September 30, 2025 and was awarded on June 30, 2022. This contract was issued...
This is a $65,183,092 cost-sharing contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Beckman Coulter, Inc. to develop and commercialize a rapid antimicrobial susceptibility testing system that can deliver results within 4-6 hours. The contract has a performance period ending on May 20, 2028. Beckman Coulter, a subsidiary of Danaher Corporation, has previously been awarded federal contracts to provide clinical laboratory technologies, supplies,...
This contract award, valued at $280,145.45, was issued by the Medical Supply Chain division of the U.S. Department of Defense to Beckman Coulter, Inc., a subsidiary of Danaher Corporation. The award is for the purchase of a BIOMEK I5 SPAN-8 WITH ENCLOSU laboratory instrument, which falls under the National Interest Action Code for the Coronavirus COVID-19 response. Beckman Coulter is a global manufacturer of biomedical testing equipment, laboratory instruments, reagents, software, and related...
This contract was awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the Department of Health and Human Services, to Meso Scale Diagnostics LLC, a small business provider of assay development, testing equipment, and immunoassays. The contract, valued at $23,234,896, is for the acquisition of assays to support COVID-19 vaccine development efforts, in response to a Broad Agency Announcement (BAA) issued by the agency. The contract is a...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Beckman Coulter, Inc., a global manufacturer of biomedical testing equipment and solutions. The $24,188 firm-fixed-price contract has a completion date of May 5, 2029 and does not have a set-aside designation. Beckman Coulter, through its U.S. Customer Operations division, is an experienced federal contractor that...
This is a $2,400,000.00 firm-fixed-price contract awarded by the U.S. Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), Center for Industrial Base Expansion and Supply Chain (IBMSC) to Watmind USA, Inc., a small disadvantaged business. The contract is to provide 1,000,000 commercial off-the-shelf multi-antigen diagnostic test kits capable of detecting SARS-CoV-2 and Influenza A/B. The objective is to ensure the government is...
This $34,714,763.00 cost-plus-fixed-fee contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Detect Inc. to advance the development of a second-generation, multi-analyte molecular SARS-CoV-2 and influenza A/B test that has a reduced time to result and increased sensitivity for use at home or in a point-of-care setting. The contract is not set aside. The award references a Broad Agency Announcement (BAA) issued by the Biomedical Advanced Research...
This federal contract award, valued at $77,399.64, was made by the Centers for Disease Control and Prevention (CDC) to Beckman Coulter, Inc., a subsidiary of Danaher Corporation, for the provision of laboratory equipment to support the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) in its COVID-19 response efforts. The contract was issued as a purchase order without any set-aside designations, indicating Beckman Coulter's unique capabilities in this specialized area....
This federal contract award to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, is for the development and delivery of a high-performance point-of-care antibody test to assess immunity to the SARS-CoV-2 virus and confirm positive antibody tests. The $275,000 Firm Fixed Price contract was awarded on June 17, 2020 by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services. This contract was not set aside...

Beckman Coulter Inc. was awarded a firm fixed price contract valued at $694,000 by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to develop the Monocyte Distribution Width (MDW) test for rapid detection of Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19 in pediatric patients. This award was made under Special Instructions 019 to the department's Easy Broad Agency Announcement BAA-20-100-SOL-0002, which sought proposals to mitigate long-term effects of respiratory distress. The work will be performed in Miami, Florida through July 2022. No subcontractors or set aside designations were identified. The contract supports the agency's goal of developing tests and therapeutics for COVID-19 related conditions like MIS-C.

Generated 12/29/23, 3:00 PM